Viridian Therapeutics, Inc.\DE

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/29/2026
Shares
1,170,829
Value ($000)
22,901
Weight
0.4%
2021 Q2 - 2026 Q1 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).